KR20030086276A - 탁산의 규칙적 투여 - Google Patents

탁산의 규칙적 투여 Download PDF

Info

Publication number
KR20030086276A
KR20030086276A KR10-2003-7011251A KR20037011251A KR20030086276A KR 20030086276 A KR20030086276 A KR 20030086276A KR 20037011251 A KR20037011251 A KR 20037011251A KR 20030086276 A KR20030086276 A KR 20030086276A
Authority
KR
South Korea
Prior art keywords
taxanes
taxane
oral
tumor
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2003-7011251A
Other languages
English (en)
Korean (ko)
Inventor
조세프 파르그놀리
윌리암 씨. 로즈
파멜라 트레일
Original Assignee
브리스톨-마이어스 스큅 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스 스큅 컴퍼니 filed Critical 브리스톨-마이어스 스큅 컴퍼니
Publication of KR20030086276A publication Critical patent/KR20030086276A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
KR10-2003-7011251A 2001-02-28 2002-02-26 탁산의 규칙적 투여 Withdrawn KR20030086276A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
US60/271,944 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number Publication Date
KR20030086276A true KR20030086276A (ko) 2003-11-07

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7011251A Withdrawn KR20030086276A (ko) 2001-02-28 2002-02-26 탁산의 규칙적 투여

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
DK1372636T3 (da) 2006-11-06
NO20033809D0 (no) 2003-08-27
SK10332003A3 (sk) 2005-03-04
ES2211374T1 (es) 2004-07-16
CA2439299A1 (en) 2002-09-06
CZ20032232A3 (en) 2004-06-16
BG108167A (en) 2004-09-30
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
PE20020955A1 (es) 2002-10-30
ZA200306450B (en) 2004-11-19
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
WO2002067928A2 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
IS6924A (is) 2003-08-22
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
UY27185A1 (es) 2002-09-30
ES2211374T3 (es) 2007-03-01
CN1533273A (zh) 2004-09-29
RU2003129233A (ru) 2005-02-10
EP1372636B1 (en) 2006-06-28
PT1372636E (pt) 2006-09-29
NO20033809L (no) 2003-10-23
CY1105468T1 (el) 2010-04-28
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
HRP20030775A2 (en) 2005-02-28
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
HUP0402115A2 (hu) 2005-02-28
EE200300413A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
US6537990B1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
JP2007538105A (ja) Gst活性化抗癌化合物による治療による別の抗癌療法の増感および/または別の抗癌療法の副作用の改善
WO2010081817A1 (en) Method for treating colorectal cancer
US20040143004A1 (en) Metronomic dosing of taxanes
JP2002507571A (ja) アントラサイクリン誘導体とカンプトテシン誘導体の相乗組合せを含有する抗腫瘍組成物
JP2003528920A (ja) 血管損傷性活性を有する併用療法
WO2009104149A1 (en) Combination comprising paclitaxel for treating ovarian cancer
CA2522980A1 (en) Water soluble wortmannin derivatives
CN109498627A (zh) 一种治疗肿瘤的药物组合物及其应用
ES2279157T3 (es) Extracto con actividad antitumoral y antivenenosa.
JP5881782B2 (ja) 医薬組成物又は組合せ剤
KR20030086276A (ko) 탁산의 규칙적 투여
CN117942345A (zh) 一种arv-825分子配体治疗nut癌方法
WO2014191989A1 (en) Conjugate of a taxane and biotin and uses thereof
RU2697551C2 (ru) Новые производные peg
AU2002254048A1 (en) Metronomic dosing of taxanes for inhibiting tumor growth
US20080176932A1 (en) Pharmaceutical Compositions Containing Baicalein And Baicalin With Synergistic Effect In Tumor Treatment
EP1623706A2 (en) Metronomic dosing of taxanes for inhibiting tumor growth
JP6488280B2 (ja) タキサン系化合物を含有する抗腫瘍剤及び抗腫瘍効果増強剤
CN116327772B (zh) SMO抑制剂Sonidegib对管腔型乳腺癌骨转移的靶向治疗方法
WO2009104152A1 (en) Combination treatment for ovarian cancer
JP4395901B2 (ja) 新規遺伝子治療用薬剤
Frontini An interesting antitumor drug in the elderly patients over the age of 70: Weekly docetaxel
JP2015199678A (ja) ラパチニブトシル酸塩水和物を含有する抗腫瘍剤及び抗腫瘍効果増強剤
CN110960679A (zh) 一种抗肿瘤的药物组合物及其应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20030827

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid